Next Article in Journal
SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma
Next Article in Special Issue
Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model
Previous Article in Journal
Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models
Previous Article in Special Issue
Trends in Liver Cancer Incidence and Survival in Italy by Histologic Type, 2003–2017
 
 
Article

Article Versions Notes

Cancers 2023, 15(3), 905; https://doi.org/10.3390/cancers15030905
Action Date Notes Link
article pdf uploaded. 31 January 2023 17:27 CET Version of Record https://www.mdpi.com/2072-6694/15/3/905/pdf-vor
article supplementary file uploaded. 31 January 2023 17:27 CET - https://www.mdpi.com/2072-6694/15/3/905#supplementary
article xml file uploaded 8 February 2023 05:08 CET Original file -
article xml uploaded. 8 February 2023 05:08 CET Update -
article pdf uploaded. 8 February 2023 05:08 CET Updated version of record https://www.mdpi.com/2072-6694/15/3/905/pdf-vor
article html file updated 8 February 2023 05:09 CET Original file -
article xml file uploaded 8 February 2023 05:11 CET Update -
article xml uploaded. 8 February 2023 05:12 CET Update https://www.mdpi.com/2072-6694/15/3/905/xml
article pdf uploaded. 8 February 2023 05:12 CET Updated version of record https://www.mdpi.com/2072-6694/15/3/905/pdf
article html file updated 8 February 2023 05:12 CET Update -
article html file updated 8 February 2023 05:13 CET Update -
article html file updated 8 March 2023 20:53 CET Update https://www.mdpi.com/2072-6694/15/3/905/html
Back to TopTop